The US Drug Industry Used To Oppose Patents – What Changed?
June 30, 2021 at 08:57 AM EDT
The United States should push for a waiver not just on the COVID-19 vaccine patents, but also all forms of intellectual property that might interfere with the transfer of the knowledge and technology necessary to manufacture these complex products.
